Literature DB >> 29319544

Review of the Xen Gel Stent and InnFocus MicroShunt.

Wesley Green1, John T Lind, Arsham Sheybani.   

Abstract

PURPOSE OF REVIEW: Two new translimbal glaucoma devices (Xen Gel Stent and InnFocus MicroShunt) have been developed with the goal of optimizing the predictability and safety for subconjunctival glaucoma surgery. RECENT
FINDINGS: The new subconjunctival glaucoma implants are manufactured from nonsilicone, biocompatible materials, which may reduce the postoperative inflammatory and fibrotic reactions that can lead to failure. Early data suggests a favorable safety profile with significant reductions in intraocular pressure (IOP). The prevention of chronic hypotony has been a hallmark of the devices, which utilize an intrinsic flow-limiting design based on the tube length and internal lumen diameter.
SUMMARY: Early data with the XEN Gel Stent and InnFocus MicroShunt show promising results. Prospective comparative studies comparing these devices with tube shunt and trabeculectomy will be needed.

Entities:  

Mesh:

Year:  2018        PMID: 29319544     DOI: 10.1097/ICU.0000000000000462

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  14 in total

1.  1-year outcomes of the Xen45 glaucoma implant.

Authors:  Michael Smith; Roselin Charles; Ahmed Abdel-Hay; Brinda Shah; Daniel Byles; Lei-Ai Lim; Jonathan Rossiter; Chih-Hung Kuo; Peter Chapman; Shalini Robertson
Journal:  Eye (Lond)       Date:  2018-12-14       Impact factor: 3.775

2.  Functional, structural, and molecular identification of lymphatic outflow from subconjunctival blebs.

Authors:  Goichi Akiyama; Sindhu Saraswathy; Thania Bogarin; Xiaojing Pan; Ernesto Barron; Tina T Wong; Mika K Kaneko; Yukinari Kato; Young Hong; Alex S Huang
Journal:  Exp Eye Res       Date:  2020-05-06       Impact factor: 3.467

3.  Visual Assessment of Aqueous Humor Outflow.

Authors:  Xiaobin Xie; Goichi Akiyama; Thania Bogarin; Sindhu Saraswathy; Alex S Huang
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019-03-27

4.  Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.

Authors:  Marta Ibarz Barberá; Fátima Martínez-Galdón; Elena Caballero-Magro; Marta Rodríguez-Piñero; Pedro Tañá-Rivero
Journal:  J Glaucoma       Date:  2022-05-17       Impact factor: 2.290

5.  Risk Factors for Glaucoma Drainage Device Failure and Complication in the Pediatric Population.

Authors:  Charles M Medert; Kara M Cavuoto; Elizabeth A Vanner; Alana L Grajewski; Ta C Chang
Journal:  Ophthalmol Glaucoma       Date:  2020-07-21

Review 6.  Microinvasive glaucoma surgery: a review and classification of implant-dependent procedures and techniques.

Authors:  Joanna Jabłońska; Katarzyna Lewczuk; Joanna Konopińska; Zofia Mariak; Marek Rękas
Journal:  Acta Ophthalmol       Date:  2021-05-14       Impact factor: 3.988

7.  Intraoperative suprachoroidal hemorrhage during Xen gel stent implantation.

Authors:  James C Liu; Wesley Green; Arsham Sheybani; John T Lind
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-25

8.  [Intraocular lens opacification after combined cataract and minimally invasive glaucoma surgery (MIGS)].

Authors:  Christoph Kern; Siegfried Priglinger; Marc J Mackert
Journal:  Ophthalmologe       Date:  2021-07       Impact factor: 1.059

9.  Effect of valproic acid on functional bleb morphology in a rabbit model of minimally invasive surgery.

Authors:  Zhu Li Yap; Li-Fong Seet; Stephanie Wl Chu; Li Zhen Toh; Farah Ilyana Ibrahim; Tina T Wong
Journal:  Br J Ophthalmol       Date:  2021-07-15       Impact factor: 5.908

10.  In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy.

Authors:  Stefano Baiocchi; Cosimo Mazzotta; Arianna Sgheri; Alessandro Di Maggio; Simone Alex Bagaglia; Matteo Posarelli; Leonardo Ciompi; Alessandro Meduri; Gian Marco Tosi
Journal:  Eye Vis (Lond)       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.